Sumitomo Mitsui Trust Group Inc. lowered its stake in Quantum-Si Incorporated (NASDAQ:QSI – Free Report) by 7.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,217,499 shares of the company’s stock after selling 403,804 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 2.58% of Quantum-Si worth $7,357,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Millennium Management LLC purchased a new position in shares of Quantum-Si during the 1st quarter worth approximately $4,721,000. Geode Capital Management LLC increased its holdings in Quantum-Si by 15.1% in the 2nd quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company’s stock worth $6,759,000 after buying an additional 452,850 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of Quantum-Si by 426.6% during the second quarter. Bank of America Corp DE now owns 465,999 shares of the company’s stock valued at $913,000 after purchasing an additional 377,504 shares during the last quarter. Ameriprise Financial Inc. purchased a new position in shares of Quantum-Si in the 2nd quarter worth $437,000. Finally, Invesco Ltd. grew its stake in shares of Quantum-Si by 88.6% during the 2nd quarter. Invesco Ltd. now owns 195,450 shares of the company’s stock valued at $383,000 after purchasing an additional 91,793 shares during the period. Institutional investors own 39.90% of the company’s stock.
Insider Activity at Quantum-Si
In related news, insider John S. Vieceli sold 21,927 shares of the stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $1.28, for a total value of $28,066.56. Following the transaction, the insider owned 800,973 shares of the company’s stock, valued at $1,025,245.44. This represents a 2.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jeffrey Alan Hawkins sold 23,707 shares of the stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $1.28, for a total value of $30,344.96. Following the transaction, the chief executive officer directly owned 2,578,018 shares in the company, valued at $3,299,863.04. The trade was a 0.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 54,261 shares of company stock valued at $69,454 in the last ninety days. Insiders own 30.04% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on Quantum-Si
Quantum-Si Stock Up 3.3%
Shares of Quantum-Si stock opened at $1.27 on Friday. The stock’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.51. Quantum-Si Incorporated has a 52 week low of $0.95 and a 52 week high of $3.10. The company has a market capitalization of $273.67 million, a PE ratio of -1.90 and a beta of 2.98.
Quantum-Si (NASDAQ:QSI – Get Free Report) last issued its earnings results on Wednesday, November 5th. The company reported ($0.17) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.17). The firm had revenue of $0.55 million during the quarter, compared to analyst estimates of $0.60 million. Quantum-Si had a negative net margin of 3,677.97% and a negative return on equity of 47.90%. As a group, research analysts anticipate that Quantum-Si Incorporated will post -0.65 earnings per share for the current year.
Quantum-Si Profile
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Recommended Stories
- Five stocks we like better than Quantum-Si
- Wall Street Alert: Buy AES
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
Want to see what other hedge funds are holding QSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quantum-Si Incorporated (NASDAQ:QSI – Free Report).
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
